Pcsa stock.

Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) announces CEO George Ng's corporate overview presentation at the Biotech Showcase 2024, focusing on developing next-gen chemotherapeutic drugs for cancer patients.The latest price target for . Processa Pharma (NASDAQ: PCSA) was reported by HC Wainwright & Co. on April 25, 2024. The analyst firm set a price target for $8.00 expecting PCSA to rise to within ...Jan 26, 2024 ... (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage ... shares of common stock (or pre-funded warrants in lieu thereof) and ...Chg %. $2.1700. -0.0900. -3.98%. Processa Pharmaceuticals Inc. advanced stock charts by MarketWatch. View PCSA historial stock data and compare to other stocks and exchanges.PCSA Dividend History. The Dividend History page provides a single page to review all of the aggregated Dividend payment information. Visit our Dividend Calendar: Our partner, Quotemedia, provides ...

Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) has announced a public offering of 1,555,555 shares of common stock and common warrants, with a combined public offering price of $4.50 per share. The gross proceeds from the offering are expected to be $7.0 million. The common warrants will have an exercise price of $4.50 per share …Find the latest historical data for Processa Pharmaceuticals, Inc. Common Stock (PCSA) at Nasdaq.com.Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) has announced a public offering of 1,555,555 shares of common stock and common warrants, with a combined public offering price of $4.50 per share. The gross proceeds from the offering are expected to be $7.0 million. The common warrants will have an exercise price of $4.50 per share …

May 10, 2024 · About MetroPCS Communications Stock (NYSE:PCS) T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

The above table shows the analyst PCSA forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$2.09Processa Pharmaceuticals Inc stock price live, this page displays NASDAQ PCSA stock exchange data. View the PCSA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Processa Pharmaceuticals Inc real time stock price chart below.PCSA stock is up about 90% as of this writing, although shares climbed more than 150% at one point today. Undergirding sentiment are encouraging safety results regarding Processa’s anti-cancer ...At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. ... Processa Pharmaceuticals, Inc. (PCSA) Add to watchlist. NasdaqCM - NasdaqCM Delayed Price. Currency in USD. 2.2200 +0.1300 (+6.22%) At …

Processa Pharmaceuticals, Inc. PCSANasdaq Stock Market. See on Supercharts. Overview. Financials News Ideas Technicals Forecast. PCSA chart. 1 day −1.88% 5 …

Potential Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) shareholders may wish to note that the Co-Founder, Patrick Lin, recently bought US$125k worth of stock, paying US$4.00 for each share.While ...

May 10, 2024 · Price vs Fair Value. View History. PCSA is trading within a range we consider fairly valued. Price. $2.06. May 10, 2024. Fair Value. $3.41. May 10, 2024. Processa Pharmaceuticals, Inc. Common Stock (PCSA) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.Find the latest SEC Filings data for Processa Pharmaceuticals, Inc. Common Stock (PCSA) at Nasdaq.com.PCSA Earnings Date and Information. Processa Pharmaceuticals last posted its earnings data on March 29th, 2024. The reported ($0.24) EPS for the quarter. Processa Pharmaceuticals has generated ($4.95) earnings per share over the last year ( ($4.95) diluted earnings per share). Earnings for Processa Pharmaceuticals are expected to … View today's Processa Pharmaceuticals Inc stock price and latest PCSA news and analysis. Create real-time notifications to follow any changes in the live stock price.

Processa Pharmaceuticals Inc share price live 1.5566, this page displays NASDAQ PCSA stock exchange data. View the PCSA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Processa Pharmaceuticals Inc real time stock price chart below. You can find more …05/06/2024 - 08:00 AM . HANOVER, Md., May 06, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs with improved efficacy and safety, today announced that management will be …Track Processa Pharmaceuticals Inc (PCSA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get …Apr 26, 2024 · Receive PCSA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Processa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PCSA) was last updated on 4/26/2024 by MarketBeat.com Staff Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the following day. After Hours trades will be posted from 4:15 p ...PCSA technical analysis. This gauge displays a real-time technical analysis overview for your selected timeframe. The summary of Processa Pharmaceuticals, Inc. is based on the most popular technical indicators, such as Moving Averages, Oscillators and Pivots. Learn more. This info isn't a recommendation for what you should personally do, so ...

Stock Price Statistics The stock price has decreased by -83.46% in the last 52 weeks. The beta is 0.53, so PCSA's price volatility has been lower than the market average.Processa Pharmaceuticals Inc. is a development-stage pharmaceutical company that uses a unique approach to develop not discover drugs that help in the treatment of oncology and other high unmet medical need diseases with unparalleled regulatory science and clinical expertise. Our drug candidates are intended for patients who have limited ...

Oct 16, 2023 · What's Happening With PCSA Stock Today? Processa Pharmaceuticals Inc (PCSA) stock is unchanged 0% while the S&P 500 has risen 0.7% as of 4:00 PM on Friday, Oct 13. PCSA is unchanged $0.00 from the previous closing price of $0.48 on volume of 19,953,405 shares. Over the past year the S&P 500 has risen 18.49% while PCSA has fallen -76.24%. Get Processa Pharmaceuticals Inc (PCSA.N) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsProcessa Pharmaceuticals Stock forecast & analyst price target predictions based on 1 analysts offering 12-months price targets for PCSA in the last 3 months.PCSA stock returns are also predicted based on historical data. According to our research, PCSA stock is a very good long-term investment. PCSA share price has been in a bull cycle for the past year. Processa Pharmaceuticals, Inc. stock trend is positive. Processa Pharmaceuticals company info. Industry: Biotechnology : Address: 7380 Coca …Stock Price Statistics The stock price has decreased by -83.46% in the last 52 weeks. The beta is 0.53, so PCSA's price volatility has been lower than the market average.The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestig...Processa Pharmaceuticals Inc (PCSA) stock has risen 4.99% while the S&P 500 is lower by -0.08% as of 9:46 AM on Monday, Mar 4. PCSA has risen $0.12 from the previous closing price of $2.46 on volume of 7,228 shares. Over the past year the S&P 500 is up 26.79% while PCSA is lower by -80.15%. PCSA lost -$22.82 per share in the over …Processa Pharma (NASDAQ: PCSA) just reported results for the first quarter of 2024. Processa Pharma reported earnings per share of -$1.11. The company did not report any revenue for the quarter ...Oct 16, 2023 · What's Happening With PCSA Stock Today? Processa Pharmaceuticals Inc (PCSA) stock is unchanged 0% while the S&P 500 has risen 0.7% as of 4:00 PM on Friday, Oct 13. PCSA is unchanged $0.00 from the previous closing price of $0.48 on volume of 19,953,405 shares. Over the past year the S&P 500 has risen 18.49% while PCSA has fallen -76.24%. Oct 25, 2016 · Find the latest PCS, PCS stock market data. Get a full understanding of how PCS is performing with stock quotes and prices, as well as real-time news and analysis.

Processa Pharmaceuticals Inc (PCSA) stock is unchanged 0% while the S&P 500 has risen 0.7% as of 4:00 PM on Friday, Oct 13. PCSA is unchanged $0.00 from the previous closing price of $0.48 on volume of 19,953,405 shares. Over the past year the S&P 500 has risen 18.49% while PCSA has fallen -76.24%. PCSA lost -$1.44 per share …

So should Processa Pharmaceuticals (NASDAQ:PCSA) shareholders be worried about its cash burn? For the purposes of this article, cash burn is the annual rate at which an unprofitable company spends ...

Find out the direct holders, institutional holders and mutual fund holders for Processa Pharmaceuticals, Inc. (PCSA).Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) announces Dr. David Young, President of Research and Development, will present at the MedInvest Oncology Investor Conference. Processa CEO George Ng will be available for one-on-one meetings with investors at the conference venue. ... N/A Ranked by Stock Gains. N/A Ranked by … At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Processa Pharmaceuticals (NASDAQ:PCSA) on Friday priced the public offering of its stock and warrants to raise gross proceeds of up to $7 million.The offering will consist of 1,555,555 shares or ...The company’s stock reached a 1-year high price of $18.00 on 10/16/23, while the lowest value for the same period was recorded at $1.45 on 04/10/24. 52-week price history of PCSA Stock. Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance.PCSA - Processa Pharmaceuticals Inc. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. ... Processa Pharmaceuticals stock price target cut to $2 from $5 at Maxim Group MarketWatch. Thursday, January 12, 2023. 07:38 AM ET. Processa Pharmaceuticals stock price …Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) announces positive outcomes from a meeting with the FDA regarding the next Phase 2 study for Next Generation Capecitabine ('NGC-Cap') for cancer patients. The FDA provided helpful guidance on the study design and dosage regimen, based on positive interim results …About MetroPCS Communications Stock (NYSE:PCS) T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will ex...May 9, 2024 · According to the issued ratings of 3 analysts in the last year, the consensus rating for Processa Pharmaceuticals stock is Moderate Buy based on the current 1 hold rating and 2 buy ratings for PCSA. The average twelve-month price prediction for Processa Pharmaceuticals is $8.00 with a high price target of $8.00 and a low price target of $8.00. PCSA Earnings Date and Information. Processa Pharmaceuticals last posted its earnings data on March 29th, 2024. The reported ($0.24) EPS for the quarter. Processa …

Bench Vices, PCB Holders, Clamps ▻ PCSA-2N from ideal-tek ▻ large selection from stock ✓ Top brands ✓ available immediately ▻ order online now!Find the latest SEC Filings data for Processa Pharmaceuticals, Inc. Common Stock (PCSA) at Nasdaq.com.PCSA stock is up about 90% as of this writing, although shares climbed more than 150% at one point today. Undergirding sentiment are encouraging safety results regarding Processa’s anti-cancer ...Instagram:https://instagram. english deutsch translateblok hotel viequesgaylord texan mapruler with measurements The latest price target for . Processa Pharma (NASDAQ: PCSA) was reported by HC Wainwright & Co. on April 25, 2024. The analyst firm set a price target for $8.00 expecting PCSA to rise to within ... Discover historical prices for PCSA stock on Yahoo Finance. View daily, weekly or monthly format back to when Processa Pharmaceuticals, Inc. stock was issued. franklin savings bankfirst service federal credit union Stock Price Forecast. The 2 analysts with 12-month price forecasts for PCSA stock have an average target of 6.00, with a low estimate of 4.00 and a high estimate of 8.00. The average target predicts an increase of 187.08% from the current stock price of 2.09. PCSA. 2.090. -1.88%. Webull offers Processa Pharmaceuticals Inc (PCSA) historical stock prices, in-depth market analysis, NASDAQ: PCSA real-time stock quote data, in-depth charts. find airpods FREE delivery for orders over £50.00 ; RS Stock No.: 787-0314 ; Mfr. Part No.: 36.PCSA-1 ; Brand: ideal-tek ...Processa Pharmaceuticals, Inc. PCSA Nasdaq Stock Market.